Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.740
-0.060 (-3.33%)
At close: Jan 23, 2026, 4:00 PM EST
1.740
0.00 (0.00%)
After-hours: Jan 23, 2026, 5:15 PM EST
Inhibikase Therapeutics Market Cap
Inhibikase Therapeutics has a market cap or net worth of $238 million as of January 23, 2026. Its market cap has decreased by -16.86% in one year.
Market Cap
238.00M
Enterprise Value
160.68M
1-Year Change
-16.86%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since the IPO on December 23, 2020, Inhibikase Therapeutics's market cap has increased from $100.46M to $238.00M, an increase of 136.92%. That is a compound annual growth rate of 18.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 238.00M | -15.12% |
| Dec 31, 2025 | 280.40M | -3.25% |
| Dec 31, 2024 | 289.83M | 3,596.14% |
| Dec 29, 2023 | 7.84M | -37.83% |
| Dec 30, 2022 | 12.61M | -65.89% |
| Dec 31, 2021 | 36.98M | -46.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enlivex Therapeutics | 256.37M |
| Crescent Biopharma | 250.24M |
| Coherus Oncology | 248.99M |
| Climb Bio | 239.68M |
| Jyong Biotech | 233.01M |
| Orchestra BioMed Holdings | 228.12M |
| Tonix Pharmaceuticals Holding | 227.01M |
| MediWound | 226.94M |